Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 16

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Silk-elastinlike copolymers enhance bioaccumulation of semisynthetic glycosaminoglycan ethers for prevention of radiation induced proctitis

Steinhauff, D., Jensen, M., Talbot, M., Jia, W., Isaacson, K., Jedrzkiewicz, J., Cappello, J., Oottamasathien, S., Ghandehari, H. · 2021 · Journal of Controlled Release

Abstract

Radiation-induced proctitis (RIP) is a debilitating adverse event that occurs commonly during lower abdominal radiotherapy. The lack of prophylactic treatment strategies leads to diminished patient quality of life, disruption of radiotherapy schedules, and limitation of radiotherapy efficacy due to dose-limiting toxicities. Semisynthetic glycosaminoglycan ethers (SAGE) demonstrate protective effects from RIP. However, low residence time in the rectal tissue limits their utility. We investigated controlled delivery of GM-0111, a SAGE analogue with demonstrated efficacy against RIP, using a series of temperature-responsive polymers to compare how distinct phase change behaviors, mechanical properties and release kinetics influence rectal bioaccumulation. Poly(lactic acid)-co-(glycolic acid)-block-poly(ethylene glycol)-block-poly(lactic acid)-co-(glycolic acid) copolymers underwent macroscopic phase separation, expelling >50% of drug during gelation. Poloxamer compositions released GM-0111 cargo within 1 hour, while silk-elastinlike copolymers (SELPs) enabled controlled release over a period of 12 hours. Bioaccumulation was evaluated using fluorescence imaging and confocal microscopy. SELP-415K, a SELP analogue with 4 silk units, 15 elastin units, and one elastin unit with lysine residues in the monomer repeats, resulted in the highest rectal bioaccumulation. SELP-415K GM-0111 compositions were then used to provide localized protection from radiation induced tissue damage in a murine model of RIP. Rectal delivery of SAGE using SELP-415K significantly reduced behavioral pain responses, and reduced animal mass loss compared to irradiated controls or treatment with traditional delivery approaches. Histological scoring showed RIP injury was ameliorated for animals treated with GM-0111 delivered by SELP-415K. The enhanced bioaccumulation provided by thermoresponsive SELPs via a liquid to semisolid transition improved rectal delivery of GM-0111 to mice and radioprotection in a RIP model.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2021.03.001

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 79

  1. Lee, 2019, ASGE guideline on the role of endoscopy for bleeding from chronic radiation proctopathy, Gastrointest. Endosc., 90, 10.1016/j.gie.2019.04.234 · DOI
  2. Mazulis, 2015, Radiation proctopathy, Radiat. Ther. Pelvic Malig. Conseq., 131, 10.1007/978-1-4939-2217-8_9 · DOI
  3. Do, 2011, Radiation Proctitis: current strategies in management, Gastroenterol. Res. Pract., 2011, 1, 10.1155/2011/917941 · doi:10.1155/2011/917941
  4. Vanneste, 2015, Chronic radiation proctitis: tricks to prevent and treat, Int. J. Color. Dis., 30, 1293, 10.1007/s00384-015-2289-4 · DOI
  5. Bansal, 2016, Exploring the management of radiation proctitis in current clinical practice, J. Clin. Diagn. Res., 10, XE01
  6. Anseline, 1981, Radiation injury of the rectum. Evaluation of surgical treatment, Ann. Surg., 194, 716, 10.1097/00000658-198112000-00010 · DOI
  7. Pricolo, 1994, Surgery for radiation injury to the large intesine, Dis. Colon Rectum, 37, 675, 10.1007/BF02054411 · doi:10.1007/bf02054411
  8. Ayerdi, 2001, Diverting loop colostomy for the treatment of refractory gastrointestinal bleeding secondary to radiation Proctitis, Mil. Med., 166, 1091, 10.1093/milmed/166.12.1091 · doi:10.1093/milmed/166.12.1091
  9. Lenz, 2016, Chronic radiation proctopathy: a practical review of endoscopic treatment, World J. Gastrointest. Surg., 8, 151, 10.4240/wjgs.v8.i2.151 · doi:10.4240/wjgs.v8.i2.151
  10. Zinicola, 2003, Haemorrhagic radiation proctitis: endoscopic severity may be useful to guide therapy, Int. J. Color. Dis., 18, 439, 10.1007/s00384-003-0487-y · doi:10.1007/s00384-003-0487-y
  11. Rustagi, 2011, Endoscopic management of chronic radiation proctitis, World J. Gastroenterol., 17, 4554, 10.3748/wjg.v17.i41.4554 · doi:10.3748/wjg.v17.i41.4554
  12. McElvanna, 2014, Sucralfate paste enema: a new method of topical treatment for haemorrhagic radiation proctitis, Color. Dis., 16, 281, 10.1111/codi.12507 · doi:10.1111/codi.12507
  13. O’Brien, 1997, A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis, Radiother. Oncol., 45, 117, 10.1016/S0167-8140(97)00146-1 · DOI
  14. Sanguineti, 2002, Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute proctitis during conformal radiotherapy for prostate carcinoma: a randomized study, Proc. 44th Annu. ASTRO Meet., 54, 110
  15. Goldstein, 1976, Treatment of chronic radiation enteritis and colitis with salicylazosulfapyridine and systemic corticosteroids. A pilot study, Am. J. Gastroenterol., 65, 201
  16. Jahraus, 2005, Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients, Int. J. Radiat. Oncol. Biol. Phys., 63, 1483, 10.1016/j.ijrobp.2005.04.032 · doi:10.1016/j.ijrobp.2005.04.032
  17. Kennedy, 2001, Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C, Am. J. Gastroenterol., 96, 1080, 10.1111/j.1572-0241.2001.03742.x · doi:10.1111/j.1572-0241.2001.03742.x
  18. Raman, 2007, Two percent formalin retention enemas for hemorrhagic radiation proctitis: a preliminary report, Dis. Colon Rectum, 50, 1032, 10.1007/s10350-007-0241-6 · doi:10.1007/s10350-007-0241-6
  19. Alfadhli, 2008, Efficacy of argon plasma coagulation compared with topical formalin application for chronic radiation proctopathy, Can. J. Gastroenterol., 22, 129, 10.1155/2008/964912 · doi:10.1155/2008/964912
  20. Ouwendijk, 2002, Local formalin instillation: an effective treatment for uncontrolled radiation-induced hemorrhagic proctitis, Dig. Surg., 19, 52, 10.1159/000052006 · doi:10.1159/000052006
  21. Vernia, 2000, Topical butyrate for acute radiation proctitis: randomised, crossover trial, Lancet., 356, 1232, 10.1016/S0140-6736(00)02787-2 · DOI
  22. Venkitaraman, 2008, Pentoxifylline to treat radiation proctitis: a small and inconclusive randomised trial, Clin. Oncol., 20, 288, 10.1016/j.clon.2008.01.012 · doi:10.1016/j.clon.2008.01.012
  23. Kim, 2008, Rebampide enema therapy as a treatment for patients with chronic radiation proctitis: initial treatment or when other methods of conservative management have failed, Int. J. Color. Dis., 23, 629, 10.1007/s00384-008-0453-9 · doi:10.1007/s00384-008-0453-9
  24. Ehrenpreis, 2005, A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy, Dis. Colon Rectum, 48, 1, 10.1007/s10350-004-0821-7 · doi:10.1007/s10350-004-0821-7
  25. Rombeau, 1999, Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis:randomized, double-blind, controlled trial, Dis. Colon Rectum, 42, 795, 10.1007/BF02236938 · doi:10.1007/bf02236938
  26. Niv, 1995, Estrogen-progestin therapy and coronary heart disease in radiation- induced rectal telangiectases, J. Clin. Gastroenterol., 21, 295, 10.1097/00004836-199512000-00009 · doi:10.1097/00004836-199512000-00009
  27. Grigsby, 1990, Preliminary results of a phase I/II study of sodium pentosanpolysulfate in the treatment of chronic radiation-induced proctitis, Am. J. Clin. Oncol., 13, 28, 10.1097/00000421-199002000-00008 · doi:10.1097/00000421-199002000-00008
  28. Khan, 2000, A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients, Am. J. Gastroenterol., 95, 1961, 10.1111/j.1572-0241.2000.02260.x · DOI
  29. Hong, 2001, Review article: current therapeutic options for radiation proctopathy, Aliment. Pharmacol. Ther., 15, 1253, 10.1046/j.1365-2036.2001.01075.x · doi:10.1046/j.1365-2036.2001.01075.x
  30. Shadad, 2013, Gastrointestinal radiation injury: prevention and treatment, World J. Gastroenterol., 19, 199, 10.3748/wjg.v19.i2.199 · DOI
  31. Hovdenak, 2005, Sucralfate does not ameliorate acute radiation proctitis: randomised study and meta-analysis, Clin. Oncol., 17, 485, 10.1016/j.clon.2005.04.011 · doi:10.1016/j.clon.2005.04.011
  32. Kneebone, 2001, The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial, Int. J. Radiat. Oncol., 51, 628, 10.1016/S0360-3016(01)01660-1 · DOI
  33. Kertesz, 2009, Effect of a prostaglandin - given rectally for prevention of radiation-induced acute proctitis - on late rectal toxicity: RRRRResults of a phase III randomized, placebo-controlled, double-blind study, Strahlentherapie Und. Onkol., 185, 596, 10.1007/s00066-009-1978-8 · doi:10.1007/s00066-009-1978-8
  34. Kneebone, 2004, Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: a double-blind, randomized trial, Int. J. Radiat. Oncol. Biol. Phys., 60, 1088, 10.1016/j.ijrobp.2004.04.033 · doi:10.1016/j.ijrobp.2004.04.033
  35. O’Brien, 2002, Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial - trans-tasman radiation oncology group, Int. J. Radiat. Oncol. Biol. Phys., 54, 442, 10.1016/S0360-3016(02)02931-0 · doi:10.1016/s0360-3016(02)02931-0
  36. Jensen, 2017, Silk-elastinlike protein polymers enhance the efficacy of a therapeutic glycosaminoglycan for prophylactic treatment of radiation-induced proctitis, J. Control. Release, 263, 46, 10.1016/j.jconrel.2017.02.025 · DOI · Paper page
  37. Savage, 2016, A modified glycosaminoglycan, GM-0111, inhibits molecular signaling involved in periodontitis, PLoS One, 11, 10.1371/journal.pone.0157310 · DOI
  38. Jensen, 2019, Temperature-responsive silk-elastinlike protein polymer enhancement of intravesical drug delivery of a therapeutic glycosaminoglycan for treatment of interstitial cystitis/painful bladder syndrome, Biomaterials., 217, 119293, 10.1016/j.biomaterials.2019.119293 · DOI · Paper page
  39. Pulsipher, 2017, Prevention of sinonasal inflammation by a synthetic glycosaminoglycan, Int. Forum Allergy Rhinol., 7, 177, 10.1002/alr.21865 · DOI
  40. Zhang, 2011, Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of Rosacea, PLoS One, 6
  41. Cappello, 1990, Genetic engineering of structural protein polymers, Biotechnol. Prog., 6, 198, 10.1021/bp00003a006 · DOI · Paper page
  42. Gustafson, 2010, Silk-elastinlike protein polymers for matrix-mediated cancer gene therapy, Adv. Drug Deliv. Rev., 62, 1509, 10.1016/j.addr.2010.04.006 · DOI
  43. Haider, 2005, Molecular engineering of silk-Elastinlike polymers for matrix-mediated gene delivery: biosynthesis and characterization, Mol. Pharm., 2, 139, 10.1021/mp049906s · DOI
  44. Dandu, 2009, Silk–elastinlike protein polymer hydrogels: influence of monomer sequence on physicochemical properties, Polymer (Guildf)., 50, 366, 10.1016/j.polymer.2008.11.047 · DOI · Paper page
  45. Barichello, 1999, Enhanced rectal absorption of insulin-loaded Pluronic® F-127 gels containing unsaturated fatty acids, Int. J. Pharm., 183, 125, 10.1016/S0378-5173(99)00090-3 · doi:10.1016/s0378-5173(99)00090-3
  46. Charrueau, 2001, Poloxamer 407 as a thermogelling and adhesive polymer for rectal administration of short-chain fatty acids, Drug Dev. Ind. Pharm., 27, 351, 10.1081/DDC-100103735 · doi:10.1081/ddc-100103735
  47. Ryu, 1999, Chang-Koo shim, increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum, J. Control. Release, 59, 163, 10.1016/S0168-3659(98)00189-8 · DOI
  48. Barakat, 2009, In vitro and in vivo characteristics of a thermogelling rectal delivery system of etodolac, AAPS PharmSciTech, 10, 724, 10.1208/s12249-009-9261-y · doi:10.1208/s12249-009-9261-y
  49. Poursaid, 2016, Silk-Elastinlike protein polymer liquid chemoembolic for localized release of doxorubicin and sorafenib, Mol. Pharm., 13, 2736, 10.1021/acs.molpharmaceut.6b00325 · DOI · Paper page
  50. Price, 2014, Effect of shear on physicochemical properties of matrix metalloproteinase responsive silk-elastinlike hydrogels, J. Control. Release, 195, 92, 10.1016/j.jconrel.2014.07.044 · DOI
  51. Gustafson, 2013, Synthesis and characterization of a matrix-metalloproteinase responsive silk-elastinlike protein polymer, Biomacromolecules., 14, 618, 10.1021/bm3013692 · DOI
  52. Rudick, 2009, Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis, BMC Urol., 9, 16, 10.1186/1471-2490-9-16 · DOI
  53. Hovdenak, 2000, Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 48, 1111, 10.1016/S0360-3016(00)00744-6 · DOI
  54. Jullien, 2009, Up-regulation of endothelin type a receptor in human and rat radiation proctitis: preclinical therapeutic approach with endothelin receptor blockade, Int. J. Radiat. Oncol., 74, 528, 10.1016/j.ijrobp.2008.12.086 · DOI
  55. Nunes, 2014, Formulation and delivery of anti-HIV rectal microbicides: advances and challenges, J. Control. Release, 194, 278, 10.1016/j.jconrel.2014.09.013 · DOI
  56. van Hoogdalem, 1991, Pharmacokinetics of rectal drug administration, part I, Clin. Pharmacokinet., 21, 11, 10.2165/00003088-199121010-00002 · doi:10.2165/00003088-199121010-00002
  57. Hua, 2019, Physiological and pharmaceutical considerations for rectal drug formulations, Front. Pharmacol., 10, 1, 10.3389/fphar.2019.01196 · DOI · Paper page
  58. Dumortier, 2006, A review of poloxamer 407 pharmaceutical and pharmacological characteristics, Pharm. Res., 23, 2709, 10.1007/s11095-006-9104-4 · DOI · Paper page
  59. Parker, 2019, Design of silk-elastin-like protein nanoparticle systems with mucoadhesive properties, J. Funct. Biomater., 10, 49, 10.3390/jfb10040049 · doi:10.3390/jfb10040049
  60. Lin, 2012, A novel in-situ-gelling liquid suppository for site-targeting delivery of anti-colorectal cancer drugs, J. Biomater. Sci. Polym. Ed., 23, 807, 10.1163/092050611X560861 · doi:10.1163/092050611x560861
  61. Ban, 2013, Design and evaluation of ondansetron liquid suppository for the treatment of emesis, Arch. Pharm. Res., 36, 586, 10.1007/s12272-013-0049-y · doi:10.1007/s12272-013-0049-y
  62. Özgüney, 2014, In vitro–in vivo evaluation of in situ gelling and thermosensitive ketoprofen liquid suppositories, Eur. J. Drug Metab. Pharmacokinet., 39, 283, 10.1007/s13318-013-0157-6 · doi:10.1007/s13318-013-0157-6
  63. Sinha, 2015, A thermo-sensitive delivery platform for topical administration of inflammatory bowel disease therapies, Gastroenterology., 149, 10.1053/j.gastro.2015.04.002 · doi:10.1053/j.gastro.2015.04.002
  64. MacDermott, 1974, Glycoprotein synthesis and secretion by mucosal biopsies of rabbit colon and human rectum, J. Clin. Invest., 54, 545, 10.1172/JCI107791 · DOI
  65. Hayashi, 1997, Transcellular and paracellular contribution to transport processes in the colorectal route, Adv. Drug Deliv. Rev., 28, 191, 10.1016/S0169-409X(97)00072-0 · DOI
  66. Porouhan, 2019, Management of radiation-induced proctitis, J. Fam. Med. Prim. Care., 8, 2173, 10.4103/jfmpc.jfmpc_333_19 · doi:10.4103/jfmpc.jfmpc_333_19
  67. Wu, 2015, Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis, Inflamm. Bowel Dis., 21, 703, 10.1097/MIB.0000000000000227 · DOI
  68. Oliveira-Nascimento, 2012, The role of TLR2 in infection and immunity, Front. Immunol., 3, 1, 10.3389/fimmu.2012.00079 · DOI · Paper page
  69. Tao, 2019, Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin a entry into cells, Nat. Microbiol., 4, 1760, 10.1038/s41564-019-0464-z · DOI
  70. Lee, 2013, Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan, PLoS One, 8, 1
  71. Martinez, 2015, Evaluation of the anti-inflammatory and antioxidant effects of the sucralfate in diversion colitis, J. Coloproctol., 35, 90, 10.1016/j.jcol.2015.02.007 · doi:10.1016/j.jcol.2015.02.007
  72. Wada, 1997, Effects of sucralfate on acute gastric mucosal injury and gastric ulcer induced by ischemia-reperf usion in rats, Pharmacology., 54, 57, 10.1159/000139470 · doi:10.1159/000139470
  73. Kochhar, 1990, Sucralfate enema in ulcerative rectosigmoid lesions, Dis. Colon Rectum, 33, 49, 10.1007/BF02053202 · doi:10.1007/bf02053202
  74. Pereira, 2013, Evaluation of sucralfate enema in experimental diversion colitis, J. Coloproctol., 33, 182, 10.1016/j.jcol.2013.08.005 · doi:10.1016/j.jcol.2013.08.005
  75. Hegemann, 2014, Hypofractionated radiotherapy for prostate cancer, Radiat. Oncol., 9, 275, 10.1186/s13014-014-0275-6 · doi:10.1186/s13014-014-0275-6
  76. De Bari, 2016, Extreme hypofractionation for early prostate cancer: biology meets technology, Cancer Treat. Rev., 50, 48, 10.1016/j.ctrv.2016.08.005 · DOI
  77. Padmanabhan, 2013, Gastrointestinal transit measurements in mice with 99mTc-DTPA-labeled activated charcoal using NanoSPECT-CT, EJNMMI Res., 3, 60, 10.1186/2191-219X-3-60 · DOI · Paper page
  78. Melo, 2019, Colorectal distribution and retention of polymeric nanoparticles following incorporation into a thermosensitive enema, Biomater. Sci., 7, 3801, 10.1039/C9BM00759H · DOI
  79. Mulè, 2010, Gastric emptying, small intestinal transit and fecal output in dystrophic (mdx) mice, J. Physiol. Sci., 60, 75, 10.1007/s12576-009-0060-8 · DOI

Cited by

See all 16

Metadata

Authors
Steinhauff, D., Jensen, M., Talbot, M., Jia, W., Isaacson, K., Jedrzkiewicz, J., Cappello, J., Oottamasathien, S., & Ghandehari, H.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2021-04
Volume
332
Pages
503-515
ISSN
0168-3659
Cited by
16
References
1
Language
en
Funders
National Institutes of Health (1RO1CA227225)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Silk-elastinlike copolymers enhance bioaccumulation of semisynthetic glycosaminoglycan ethers for prevention of radiation induced proctitis. https://app.cochat.ai/papers/10.1016/j.jconrel.2021.03.001
The paper
Steinhauff, D., Jensen, M., Talbot, M., Jia, W., Isaacson, K., Jedrzkiewicz, J., Cappello, J., Oottamasathien, S., & Ghandehari, H. (2021). Silk-elastinlike copolymers enhance bioaccumulation of semisynthetic glycosaminoglycan ethers for prevention of radiation induced proctitis. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2021.03.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.